Lv12
90 积分 2021-08-26 加入
Evaluation of the effects of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease
1个月前
已完结
Wheat germ improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled, double-blind clinical trial
1个月前
已完结
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
1个月前
已完结
Impact of dapagliflozin, an SGLT2 inhibitor, on serum levels of soluble dipeptidyl peptidase-4 in patients with type 2 diabetes and non-alcoholic fatty liver disease
3个月前
已完结
Empagliflozin versus sitagliptin for ameliorating intrahepatic lipid content and tissue-specific insulin sensitivity in patients with early-stage type 2 diabetes with non-alcoholic fatty liver disease: A prospective randomized study
3个月前
已完结
Long-Read Sequencing Identifies Novel Pathogenic Intronic Variants in Gitelman Syndrome
4个月前
已完结
Pure Gitelman-like syndrome secondary to SLC26A4 (pendrin) mutation
4个月前
已完结
Gitelman-Like Syndrome Caused by Pathogenic Variants in mtDNA
4个月前
已完结
Spectrum of Mutations in Gitelman Syndrome
4个月前
已完结
Morus alba L. (Sangzhi) alkaloids (SZ-A) exert anti-inflammatory effects via regulation of MAPK signaling in macrophages
5个月前
已完结
皖公网安备34019202002308
